Virtual screening is a powerful tool in drug discovery, with the potential to find novel ligands for therapeutically relevant target structures. However, the field is plagued by both false positive and false negative predictions. This is due to approximations within the scoring functions, leading to the failure to distinguish between true ligands and high-ranking nonbinders (decoys). To compound the problem, in a typical target the complexity of the ligand-receptor interactions prevents us from unraveling the many components of the binding energy that lead to the incorrect predictions. Model binding sites provide simpler systems in which individual terms can be isolated and studied.
In Chapter 1, cytochrome c peroxidase (CCP) W191G, an anionic, wet, and buried cavity is introduced. This cavity primarily binds aromatic monocations; dications and most neutral molecules do not bind detectably. In Chapter 2, CCP W191G is included in a series of model systems (the T4 lysozyme L99A hydrophobic and L99A/M102Q polar cavities) to evaluate MM-GBSA rescoring of docking hit lists; both chapters consider the case for CCP W191G where the scoring function must balance the cost of ligand desolvation with the favorable electrostatic interaction energy between ligand and protein.
Chapter 3 returns to the T4 lysozyme L99A/M102Q polar models system for absolute and relative binding free energy predictions. This system proved to be difficult for the free energy methods, but not due to the additional polarity, as we had initially predicted. Instead, protein conformational change, sampling of reasonable ligand orientations and methodological failures proved a challenge to accurate predictions.
In the final chapter, a new open cavity in cytochrome c peroxidase, created by the W191G\P190G ΔG192-A193 deletion mutant is introduced. The cavity contains multiple ordered waters and an interface to bulk solvent. This more complicated cavity presents an opportunity to investigate displacing individual ordered waters, and the potential for neutral ligands in a charged cavity. Implications for this new charged, open cavity and preliminary results are discussed in Chapter 4: Future Directions.
|Advisor:||Shoichet, Brian K.|
|Commitee:||Dill, Ken A., Jacobson, Matthew P.|
|School:||University of California, San Francisco|
|Department:||Chemistry and Chemical Biology|
|School Location:||United States -- California|
|Source:||DAI-B 71/02, Dissertation Abstracts International|
|Subjects:||Pharmacy sciences, Physical chemistry|
|Keywords:||Drug discovery, Model systems, Molecular docking, Virtual screening|
Copyright in each Dissertation and Thesis is retained by the author. All Rights Reserved
The supplemental file or files you are about to download were provided to ProQuest by the author as part of a
dissertation or thesis. The supplemental files are provided "AS IS" without warranty. ProQuest is not responsible for the
content, format or impact on the supplemental file(s) on our system. in some cases, the file type may be unknown or
may be a .exe file. We recommend caution as you open such files.
Copyright of the original materials contained in the supplemental file is retained by the author and your access to the
supplemental files is subject to the ProQuest Terms and Conditions of use.
Depending on the size of the file(s) you are downloading, the system may take some time to download them. Please be